Berkeley Capital Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 1667694 Milton, GA

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,632,424

+$366,821 QoQ

Shares Held

1,361

-1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#2,689

of 4,605 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. LLY ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	12,370	$3,141,608
2	MRK	Merck & Co., Inc.	17,441	$2,241,168
3	ABBV	AbbVie Inc.	7,720	$1,942,660
4	LLY	ELI LILLY & Co This page	1,361	$1,632,424
5	NVS	Novartis AG	10,041	$1,573,625
6	PFE	Pfizer Inc	64,286	$1,548,006
7	BMY	Bristol Myers Squibb Co	25,331	$1,459,572
8	NVO	Novo Nordisk A S	6,115	$293,153

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,632,424	1,361	-1.1%	Shares	Sole	2026-08-06
2026-03-31	$1,265,603	1,376	+5.0%	Shares	Sole	2026-05-07
2025-12-31	$1,408,905	1,311	+2.3%	Shares	Sole	2026-02-05
2025-09-30	$977,403	1,281	+3.3%	Shares	Sole	2025-11-10
2025-06-30	$966,617	1,240	-8.8%	Shares	Sole	2025-07-30
2025-03-31	$1,123,237	1,360	+4.1%	Shares	Sole	2025-05-05
2024-12-31	$1,008,232	1,306	-0.2%	Shares	Sole	2025-02-11
2024-09-30	$1,158,809	1,308	+8.2%	Shares	Sole	2024-11-14
2024-06-30	$1,094,604	1,209	+12.3%	Shares	Sole	2024-08-14
2024-03-31	$837,862	1,077	+23.9%	Shares	Sole	2024-05-14
2023-12-31	$506,557	869	+39.7%	Shares	Sole	2024-02-09
2023-09-30	$334,094	622	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.